Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Aegis Awarded Patent for Absorption-Enhancing Self-Assembling Thixotropic Aqueous Hydrogels

SAN DIEGO, CA -- (Marketwire) -- 12/11/12 -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,329,220 providing proprietary compositions for absorption-enhancing self-assembling aqueous hydrogels useful for extended release, transdermal, or transmucosal absorption enhancement for peptide and small molecule drug delivery applications. The Aegis Hydrogels™ serve simultaneously as both delivery vehicle and absorption enhancer. In dermal applications, these hydrogels immediately absorb into the skin with no sense of any residue remaining. In sustained release depot applications, unlike current depot matrices which require large gauge needles for delivery resulting in significant and unnecessary patient discomfort, the thixotropic nature of these gels allows liquid-like flow through fine-gauge needles (28 gauge or 31 gauge) with resumption of the stable gel form immediately upon exiting the needle.

The company is seeking licensees for prescription and OTC applications of the Aegis Hydrogels™.

About Aegis Therapeutics

Aegis Therapeutics LLC is a drug delivery technology company commercializing its patented drug delivery and drug formulation technologies through product-specific licenses. Our Intravail® drug delivery technology enables the non-invasive delivery of a broad range of protein, peptide and non-peptide drugs that can currently only be administered by injection, via the oral, buccal, and intranasal administration routes, and with high bioavailability. Our ProTek® excipients stabilize, prevent aggregation, and reduce unwanted immunogenicity of protein and peptide therapeutics while avoiding the oxidative damage caused by polysorbate surfactants currently found in most protein injectable drugs.

For more information about Aegis, please visit: http://www.aegisthera.com.

Contact:
Ralph Barry
Chief Business Officer
Aegis Therapeutics LLC
1-858-618-1400 Ext. 102
Email: Email Contact

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
Does a Content Delivery Network (CDN) protect against Distributed Denial of Service (DDoS) attacks? It’s a good question. A CDN by its very nature will absorb DDoS attacks for the content that it serves and this could be considered protection but, as is often the case, this is only the...
Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises are u...
The explosion of cloud onto the enterprise scene has, literally, revolutionized how businesses across the size spectrum do business, yet there’s a price tag tucked into this cloud’s silver lining that smart decision-makers should pay heed to. This is the era of what I like to call the...
Just as writing has come to mean texting, blogging or any form of digital writing, the cloud today means one or all of the three Cs: computing, connectivity and communication. And just as nearly all thought to putting pen to paper has disappeared, all reference to the natural cloud is ...
Yes, Lori has been reading the Internet again. And what she’s been seeing makes baby Lori angry. It also makes this former test designer and technology editor cry. Really, I weep at both the excuses offered for such testing and the misleading headline. I have read no less than two con...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE